Quoin Pharmaceuticals, Ltd.

Nasdaq:QNRX

Pharmaceutical Preparations·KFAR SABA

Quoins are masonry blocks at the corner of a wall. Some are structural, providing strength for a wall made with inferior stone or rubble, while others merely add aesthetic detail to a corner.

CEO

Myers Michael

CFO

Lawlor Sally Bridget

Financials

12 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/13/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

11 shown

Filed	Period
11/6/25	Nov 2025	→
8/7/25	Aug 2025	→
5/14/25	May 2025	→
3/13/25	Mar 2025	→
11/8/24	Nov 2024	→
8/14/24	Aug 2024	→
↓

News (8-K)

42 shown

Filed	Type	Description
1/20/26	Reg FD	Regulation FD Disclosure	→
11/17/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/12/25	Reg FD	Regulation FD Disclosure	→
10/21/25	Reg FD	Regulation FD Disclosure	→
10/15/25	Agreement	Entry into a Material Definitive Agreement	→
8/27/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/5/25	424B3	424B3	→
11/7/25	S-3	S-3	→
8/27/25	S-8	S-8	→
8/25/25	S-8	S-8	→
7/17/25	ARS	ARS	→
12/23/24	424B4	424B4	→
↓

Filing History(537 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Feb 17, 2026

0001104659-26-016659

—

20.2 KB

SCHEDULE 13G

Feb 17, 2026

0000902664-26-001060

—

9.1 KB

SCHEDULE 13G/A

Feb 11, 2026

0001104659-26-013497

—

18.4 KB

SCHEDULE 13G/A

Feb 6, 2026

0001193125-26-041438

—

11.9 KB

Feb 6, 2026

0001104659-26-011623OWNERSHIP DOCUMENT

Feb 4, 2026

6.0 KB

Feb 6, 2026

0001104659-26-011622OWNERSHIP DOCUMENT

Feb 4, 2026

5.9 KB

Feb 6, 2026

0001104659-26-011617OWNERSHIP DOCUMENT

Feb 4, 2026

6.0 KB

Feb 6, 2026

0001104659-26-011616OWNERSHIP DOCUMENT

Feb 4, 2026

5.9 KB

Feb 6, 2026

0001104659-26-011615OWNERSHIP DOCUMENT

Feb 4, 2026

5.9 KB

Feb 6, 2026

0001104659-26-011613OWNERSHIP DOCUMENT

Feb 4, 2026

5.9 KB

Feb 6, 2026

0001104659-26-011610OWNERSHIP DOCUMENT

Feb 4, 2026

5.9 KB

Feb 6, 2026

0001104659-26-011608OWNERSHIP DOCUMENT

Feb 4, 2026

5.9 KB

SCHEDULE 13G/A

Feb 2, 2026

0000935836-26-000065

—

20.1 KB

Feb 2, 2026

0000935836-26-000064

Jan 29, 2026

12.7 KB

SCHEDULE 13G

Jan 28, 2026

0001716774-26-000006

—

8.7 KB

8-K

Jan 20, 2026

0001104659-26-005127FORM 8-K

Jan 20, 2026

219.5 KB

SCHEDULE 13G

Dec 16, 2025

0000935836-25-000719

—

19.6 KB

SCHEDULE 13G

Dec 15, 2025

0001193125-25-319730

—

130.1 KB

SCHEDULE 13G

Dec 11, 2025

0001834913-25-000006

—

8.2 KB

424B3

Dec 5, 2025

0001104659-25-118662424B3

—

214.4 KB

EFFECT

Dec 4, 2025

9999999995-25-003536

—

1.9 KB

Dec 3, 2025

0001104659-25-118190OWNERSHIP DOCUMENT

Dec 1, 2025

6.2 KB

8-K

Nov 17, 2025

0001104659-25-113237FORM 8-K

Nov 14, 2025

259.0 KB

8-K

Nov 12, 2025

0001104659-25-109802FORM 8-K

Nov 11, 2025

213.5 KB

S-3

Nov 7, 2025

0001104659-25-108536FORM S-3

—

458.0 KB

25 filings shown

Filed	Form	Description
7/17/25	DEF 14A	DEF 14A	→
7/7/25	PRE 14A	FORM PRE14A	→
10/24/24	DEF 14A	DEF 14A	→
10/11/24	PRE 14A	PRE 14A	→
4/2/24	DEFA14A	DEFA14A	→
2/27/24	DEF 14A	DEF 14A	→
↓

Quoin Pharmaceuticals, Ltd.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(537 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/6/26	4	OWNERSHIP DOCUMENT	→
2/6/26	4	OWNERSHIP DOCUMENT	→
2/6/26	4	OWNERSHIP DOCUMENT	→
2/6/26	4	OWNERSHIP DOCUMENT	→
2/6/26	4	OWNERSHIP DOCUMENT	→
2/6/26	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/11/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/6/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/2/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/28/26	SCHEDULE 13G	SCHEDULE 13G	→
↓